Pharmaceutical Technologists, Process Scientists and Process Engineers, Process Validation Specialists, CMO Managers, Technology Transfer Specialists, Manufacturing Management, Regulatory Affairs Managers, Quality Assurance Managers, Manufacturing Project Management
This two-day interactive course is intended to provide insight how state-of-the-artProcess Scale-up, Technology Transfer and modern Process Validation are tied together by applying Quality by Design principles. The regulatory requirements will be explained, and case studies and workshop exercises will help you understand on how to translate theory into practice and overcome frequently faced challenges.
✓ Training materials will be provided in printed and digital form
✓ All delegates will receive printed and LinkedIn certificates
✓ 5 hours of networkingwith industry peers
✓ Networking cocktail reception
Director Late Stage Drug Product Development
Boehringer Ingelheim Pharma
Dr. Braun is a trained pharmacist with 20 years of experience in Drug Product Development. He received his Ph.D. in Pharmaceutical Technology at the University of Bonn and started his career in pharmaceutical industry as Head of Pharmaceutical Development at Rentschler Pharma. In 2006 Michael joined Boehringer Ingelheim and worked in different positions with increasing responsibility within Pharmaceutical Development and R&D Project Management. Since 2014 he is Director Late Stage Drug Product Development and responsible for process development and scale-up of solid and liquid orals, parenterals and inhalative NCE products. This also includes product transfers to operations, launch support and preparation of submission documentation.
Director Late Stage Drug Product Development
Boehringer Ingelheim Pharma
Dr. Braun is a trained pharmacist with 20 years of experience in Drug Product Development. He received his Ph.D. in Pharmaceutical Technology at the University of Bonn and started his career in pharmaceutical industry as Head of Pharmaceutical Development at Rentschler Pharma. In 2006 Michael joined Boehringer Ingelheim and worked in different positions with increasing responsibility within Pharmaceutical Development and R&D Project Management. Since 2014 he is Director Late Stage Drug Product Development and responsible for process development and scale-up of solid and liquid orals, parenterals and inhalative NCE products. This also includes product transfers to operations, launch support and preparation of submission documentation.
For the detailed agenda with a full breakdown of the individual sessions fill out this form.
